Carboprost
| Clinical data | |
|---|---|
| Trade names | Hemabate | 
| AHFS/Drugs.com | Micromedex Detailed Consumer Information | 
| MedlinePlus | a600042 | 
| Pregnancy category | 
 | 
| Routes of administration | Intramuscular | 
| ATC code | |
| Legal status | |
| Legal status | 
 | 
| Identifiers | |
| 
 | |
| CAS Number | 
 | 
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | 
 | 
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C21H36O5 | 
| Molar mass | 368.514 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
| (what is this?) (verify) | |
Carboprost (INN, trade names for the tromethamine salts Hemabate, Tham) is a synthetic prostaglandin analogue of PGF2α (specifically, it is 15-methyl-PGF2α) with oxytocic properties.
Carboprost's main use is to reduce postpartum bleeding during the obstetrical emergency of postpartum hemorrhage.